{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:09:22Z","timestamp":1761894562013},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,6,15]],"date-time":"2007-06-15T00:00:00Z","timestamp":1181865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s00393-007-0185-1","type":"journal-article","created":{"date-parts":[[2007,6,14]],"date-time":"2007-06-14T12:17:00Z","timestamp":1181823420000},"page":"522-524","source":"Crossref","is-referenced-by-count":3,"title":["Krankheitsmodifizierende Effekte bei der rheumatoiden Arthritis durch Glukokortikoide","Disease-modifying effects of glucocorticoids in rheumatoid arthritis"],"prefix":"10.1007","volume":"66","author":[{"given":"F.","family":"Buttgereit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Kommission Pharmakotherapie der DGRh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,15]]},"reference":[{"key":"185_CR1","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1002\/art.20583","volume":"50","author":"Buttgereit","year":"2004","unstructured":"Buttgereit F, Straub RH, Wehling M, Burmester GR (2004) Glucocorticoids in the treatment of rheumatic diseases. An update on mechanisms of action. Arthritis Rheum 50: 3408\u20133417","journal-title":"Arthritis Rheum"},{"key":"185_CR2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1351.025","volume":"1069","author":"Bijlsma","year":"2006","unstructured":"Bijlsma JWJ, Hoes JN, van Everdingen AA (2006) Are Glucocorticoids DMARDs? Ann N Y Acad Sci 1069: 268\u2013274","journal-title":"Ann N Y Acad Sci"},{"key":"185_CR3","doi-asserted-by":"crossref","unstructured":"Bijlsma JWF, Buttgereit F, Jacobs JWG (2006) Systemic and intra-articular glucocorticoids in rheumatoid arthritis. In: Firestein GS, Panayi GS, Wollheim FA (eds) Rheumatoid Arthritis. Oxford University Press, pp\u00a0337\u2013354","DOI":"10.1093\/oso\/9780198566304.003.0023"},{"key":"185_CR4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/03009740510017706","volume":"34","author":"Buttgereit","year":"2005","unstructured":"Buttgereit F, Saag K, Cutolo M et al. (2005) The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheum 34:14\u201321","journal-title":"Scand J Rheum"},{"key":"185_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-136-1-200201010-00006","volume":"136","author":"Van","year":"2002","unstructured":"Van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW (2002) Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 136: 1\u201312","journal-title":"Ann Intern Med"},{"key":"185_CR6","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/art.21809","volume":"54","author":"Jacobs","year":"2006","unstructured":"Jacobs JW, van Everdingen AA, Verstappen SMM, Bijlsma JW (2006) Follow-up radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placebo. Arthritis Rheum 54: 1422\u20131428","journal-title":"Arthritis Rheum"},{"key":"185_CR7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199507203330302","volume":"333","author":"Kirwan","year":"1995","unstructured":"Kirwan JR (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 333: 142\u2013146","journal-title":"N Engl J Med"},{"key":"185_CR8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(97)01300-7","volume":"350","author":"Boers","year":"1997","unstructured":"Boers M, Verhoeven AC, Markusse HM et al. (1997) Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350: 309\u2013318","journal-title":"Lancet"},{"key":"185_CR9","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1002\/art.21421","volume":"52","author":"Wassenberg","year":"2005","unstructured":"Wassenberg S, Rau R, Steinfeld P, Zeidler H (2005) Very low prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double blind placebo-controlled trial. Arthritis Rheum 52: 3371\u20133380","journal-title":"Arthritis Rheum"},{"key":"185_CR10","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/art.21298","volume":"52","author":"Svensson","year":"2005","unstructured":"Svensson B, Boonen A, Albertsson K et al. (2005) Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis Rheum 52: 3360\u20133370","journal-title":"Arthritis Rheum"},{"key":"185_CR11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/ard.2003.014050","volume":"63","author":"Capell","year":"2004","unstructured":"Capell HA, Madhok R, Hunter JA et al. (2004) Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis 63: 797\u2013803","journal-title":"Ann Rheum Dis"},{"key":"185_CR12","unstructured":"Kirwan JBijlsma JWJ, Boers M, Shea B (2007) Effects of glucocorticoids on radiological progession in rheumatoid arthritis. Cochrane Databas Syst Rev Jan 24;1:CD006356"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0185-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-007-0185-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0185-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T02:39:40Z","timestamp":1707964780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-007-0185-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,15]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1007\/s00393-007-0185-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2007,6,15]]}}}